Administration of second dose SARS-CoV-2 non-replicating viral vector vaccine
Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
procedure
Supplier: international · SCTID 1157108008
Also known as (14)
- Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
- Second 2019 novel coronavirus non-replicating viral vector immunisation
- Second 2019 novel coronavirus non-replicating viral vector immunization
- Second 2019 novel coronavirus non-replicating viral vector vaccination
- Second 2019-nCoV non-replicating viral vector immunisation
- Second 2019-nCoV non-replicating viral vector immunization
- Second 2019-nCoV non-replicating viral vector vaccination
- Second COVID-19 non-replicating viral vector immunisation
- Second COVID-19 non-replicating viral vector immunization
- Second COVID-19 non-replicating viral vector vaccination
- Second SARS-CoV-2 non-replicating viral vector immunisation
- Second SARS-CoV-2 non-replicating viral vector immunization
- Second SARS-CoV-2 non-replicating viral vector vaccination
- Second severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccination